Skip to main content
. Author manuscript; available in PMC: 2016 Mar 29.
Published in final edited form as: J Telemed Telecare. 2013 Mar 25;19(2):107–112. doi: 10.1258/jtt.2012.120509

Table 1.

Sample characteristics (n=403)

Demographics All n (%) High illness Low illness Males Females Age<75 years Age 75-84 years Age>84 years

Total 403 (100) 219 (54) 184 (46) 181 (45) 222 (55) 78 (19) 110 (27) 215 (53)

Age
 <60 10 (3) 7 (3) 3 (2) 6 (3) 4 (2) 10 (13)
 60–64 11 (3) 7 (3) 4 (2) 6 (3) 5 (2) 11 (14)
 65–74 57 (14) 35 (17) 22 (11) 30 (17) 27 (12) 57 (73)
 75–84 110 (27) 62 (30) 48 (25) 56 (31) 54 (24) 110 (100)
 85–94 185 (46) 83 (40) 102 (53) 74 (419) 111 (50) 185 (86)
 >94 30 (8) 15 (7) 15 (8) 9 (5) 21 (10) 30 (14)
Race
 American Indian/Alaska Native 2 (0.5) 1 (0.5) 1 (0.5) 1 (0.6) 1 (0.5) 1 (1) 1 (0.9) 0
 Asian 4 (1) 3 (1) 1 (0.5) 3 (2) 1 (0.5) 0 2 (2) 2 (0.9)
 African American 9 (2) 4 (2) 5 (3) 4 (2) 5 (2) 6 (8) 1 (0.9) 2 (0.9)
 Hispanic or Latino 5 (1) 4 (2) 1 (0.5) 3 (2) 2 (0.9) 4 (5) 1 (0.9) 0
 Native Hawaiian/Pacific Islander 0 0 0 0 0 0 0 0
 White 382 (95) 197 (94) 185 (95) 169 (93) 213 (96) 66 (85) 105 (96) 211 (98)
 Unknown 1 (0.2) 0 1 (0.5) 1 (0.6) 0 0 0 0
Gender
 Males 181 (45) 99 (47) 82 (42) 181 (100) 42 (54) 56 (519) 83 (39)
 Females 222 (55) 110 (53) 112 (58) 222 (100) 36 (46) 54 (49) 132 (61)
Location
 Rural 42 (10) 17 (8) 25 (13) 24 (13) 18 (8) 8 (10) 14 (13) 20 (9)
 Urban 361 (90) 192 (92) 169 (87) 157 (87) 204 (92) 70 (90) 96 (87) 195 (91)
Non-English ability 10 (3) 7 (3) 3 (2) 6 (3) 4 (2) 0 3 (3) 7 (3)

Psychosocial status n (%)

Cognitive functioning
0 - Alert 224 (55.6) 112 (53.6) 112 (57.7) 105 (58.0) 119 (53.6) 52 (66.7) 70 (63.6) 102 (47.4)
1 - Requires prompting during stress 139 (34.5) 75 (35.9) 64 (33.0) 62 (34.3) 77 (34.7) 22 (28.2) 32 (29.1) 85 (39.5)
2 - Requires direction for specific situation 32 (7.9) 16 (7.7) 16 (8.2) 12 (6.6) 20 (9.0) 4 (5.1) 6 (5.5) 22 (10.2)
3 - Requires considerable assistance 6 (1.5) 4 (1.9) 2 (1.0) 3 (0.6) 5 (2.3) 0 1 (0.9) 5 (2.3)
4 - Totally dependant 2 (0.5) 2 (1.0) 0 1 (0.6) 1 (0.5) 0 1 (0.9) 1 (0.5)
Anxiety
0 - No anxiety 234 (58.1) 101 (48.3) 133 (68.6) 113 (62.4) 121 (54.5) 41 (52.6) 57 (51.8) 136 (63.3)
1 - Less often than daily 91 (22.6) 44 (21.1) 47 (24.2) 34 (18.8) 57 (25.7) 16 (20.5) 26 (23.6) 49 (22.8)
2 - Daily, not constantly 73 (18.1) 59 (28.2) 14 (7.2) 32 (17.7) 41 (18.5) 18 (23.1) 26 (23.6) 29 (13.5)
3 - All the time 5 (1.2) 5 (2.4) 0 2 (1.1) 3 (1.4) 3 (3.8) 1 (0.9) 1 (0.5)
Depression 70 (17.4) 47 (22.5) 23 (11.9) 33 (18.2) 37 (16.7) 24 (30.8) 17 (15.5) 29 (13.5)
Living situation
 Living alone 122 (30.3) 59 (28.2) 63 (32.5) 43 (23.8) 79 (35.6) 21 (26.9) 32 (29.1) 69 (32.1)
 Living with others 281 (69.7) 150 (71.8) 131 (67.5) 138(76.2) 143(64.4) 57 (73.1) 78 (70.9) 146(67.9)

HF disease characteristics n (%)/Mean (SD)
Range

Type of HF diagnosis
 Primary 190 (47.9) 102 (46.6) 88 (47.8) 81 (44.8) 109 (49.1) 24 (30.8) 47 (42.7) 119 (55.3)
 Secondary 213 (52.1) 117 (53.4) 96 (52.2) 100 (55.2) 113 (50.9) 54 (69.2) 63 (57.3) 96 (44.7)
Status of HF diagnosis
 Newly diagnosed 33 (8.2) 18 (8.6) 15 (7.7) 15 (8.3) 18 (8.1) 6 (7.7) 10 (9.1) 17 (7.9)
 Chronic HF 327 (81.1) 169 (80.9) 158 (81.4) 147 (81.2) 180 (81.1) 62 (79.5) 86 (78.2) 179 (83.3)
 Unknown 43 (10.7) 22 (10.5) 21 (10.8) 19 (10.5) 24 (10.8) 10 (12.8) 14 (12.7) 19 (8.8)
Ambulation (at admission)
0 – Independently walk 31 (7.7) 14 (6.7) 17 (8.8) 21 (11.6) 10 (4.5) 8 (10.3) 14 (12.7) 9 (4.2)
1- Use of a device to walk 283 (70.2) 137 (65.6) 146 (75.3) 128 (70.7) 155 (69.8) 58 (74.4) 82 (74.5) 143 (66.5)
2 – Supervised walking only 79 (19.6) 49 (23.4) 30 (15.5) 30 (16.6) 49 (22.1) 10 (12.8) 12 (10.9) 57 (26.5)
3 – Chairfast, independent using wheelchair 5 (1.2) 5 (2.4) 1 (0.5) 2 (1.1) 3 (1.4) 1 (1.3) 2 (1.8) 2 (0.9)
4 – Chairfast, unable to wheel self 5 (1.2) 4 (1.9) 0 0 5 (2.3) 1 (1.3) 0 4 (1.9)
5 – Bedbound 0 0 0 0 0 0 0 0
Dyspnea (at admission)
 0 - Never 24 (6.0) 9 (4.3) 15 (7.7) 7 (3.9) 17 (7.7) 3 (3.8) 4 (3.6) 17 (7.9)
 1 – Climbing stairs 133 (33.0) 43 (20.6) 90 (46.4) 68 (37.6) 65 (29.3) 28 (35.9) 33 (30.0) 72 (33.5)
 2 – With dressing, bathing 152 (37.7) 63 (30.1) 89 (45.9) 59 (32.6) 93 (41.9) 26 (33.3) 47 (42.7) 79 (36.7)
 3 – With eating, conversation 76 (18.9) 76 (36.4) 0 38 (21.0) 38 (17.1) 19 (24.4) 22 (20.0) 35 (16.3)
 4 – At rest 18 (4.5) 18 (8.6) 0 9 (5.0) 9 (4.1) 2 (2.6) 4 (3.6) 12 (5.6)
No of co-morbidities 5.19 (1.9) 6.06 (2.1) 4.25 (1.9) 4 5.4 (1.9) 5.01 (1.9) 5.55 (2.2) 5. 27 (1.9) 5. 01 (1.8)
10 (1 – 11) 10 (1-11) (2 – 6) 10 (1 –11) 9 (2 – 11) 9 (2 – 11) 9 (2 – 11) 10 (1 – 11)
Type of co-morbidity
 a) Blood pressure 277 (68.7) 143 (68.4) 134 (69.1) 123 (68.0) 154 (69.4) 51 (65.4) 77 (70.0) 149 (69.3)
 b) Vascular 269 (66.8) 157 (75.1) 116 (59.8) 141 (77.9) 132 (59.5) 54 (69.2) 76 (69.1) 143 (66.5)
 c) Cardiac Arrhythmia 213 (52.9) 109 (52.2) 100 (51.5) 92 (50.8) 121 (54.5) 35 (44.9) 57 (51.8) 121(56.3)
 d) Pulmonary 185 (45.9) 126 (60.3) 59 (30.4) 83 (45.9) 102 (45.9) 47 (60.3) 57 (51.8) 81 (37.7)
 e) Diabetes mellitus 144 (35.7) 88 (42.1) 56 (28.9) 74 (40.9) 70 (31.5) 43 (55.1) 50 (45.5) 51 (23.7)
 f) Musculoskeletal 140 (34.7) 89 (42.6) 51 (26.3) 62 (34.3) 78 (35.1) 22 (28.2) 40 (36.4) 78 (36.3)
 g) Renal 97 (24.1) 66 (31.6) 31 (16.0) 52 (28.7) 45 (20.3) 17 (21.8) 26 (23.6) 54 (25.1)
 h) Thyroid 86 (21.3) 58 (27.8) 28 (14.4) 26 (14.4) 60 (27.0) 14 (17.9) 17 (15.5) 55 (25.6)
 i) Gastro-intestinal 82 (20.4) 56 (26.8) 26 (13.4) 37 (20.4) 45 (20.3) 13 (16.7) 22 (20.0) 47 (21.9)
 j) Anaemia 72 (17.9) 37 (17.7) 35(18.0) 25 (13.8) 47 (21.2) 11 (14.1) 16 (14.5) 45 (20.9)
 k) Depression 55 (13.6) 36 (17.2) 19 (9.8) 23 (12.7) 32 (14.4) 15 (19.2) 14 (12.7) 26 (12.1)
 l) Benign prostrate hyperplasia(BPH) 48 (11.9) 31 (14.8) 17 (8.8) 48 (26.5) 0 6 (7.7) 15 (13.6) 27 (12.6)
 m) Neurological 42 (10.4) 24 (11.5) 18 (9.3) 19 (10.5) 23 (10.4) 7 (9.0) 8 (7.3) 27 (12.6)
 n) Dementia 33 (8.2) 19 (9.1) 14 (7.2) 19 (10.5) 14 (6.3) 2 (2.6) 9 (8.2) 22 (10.2)
 o) Anxiety 32 (7.9) 25 (12.0) 7 (3.6) 8 (4.4) 23 (10.4) 9 (11.5) 5 (4.5) 17 (7.9)
 p) Valvular 31 (7.7) 12 (5.7) 19 (9.8) 14 (7.73) 13 (5.8) 11 (14.1) 4 (3.6) 13 (6.0)
 q) Cancer 23 (5.7) 12 (5.7) 11 (5.7) 9 (5.0) 14 (6.3) 6 (7.7) 10 (9.1) 7 (3.3)
 r) Post acute cardiac Event (e.g: MI) 21 (5.2) 12 (5.7) 9 (4.6) 10 (5.5) 11 (5.0) 5 (6.4) 4 (3.6) 12 (5.6)
 s) Obesity 17 (4.2) 14 (6.7) 3 (1.5) 5 (2.8) 12 (5.4) 11 (14.1) 3 (2.7) 3 (1.4)
 t) Skin disorders 15 (3.7) 9 (4.3) 6 (3.1) 5 (2.8) 10 (4.5) 3 (3.8) 4 (3.6) 8 (3.7)
 u) Nutrition disorders/metabolic 9 (2.2) 5 (2.4) 4 (2.1) 2 (1.1) 7 (3.2) 2 (2.6) 3 (2.7) 4 (1.9)
 v)Infection 4 (1) 2 (1.0) 2 (1.0) 1 (0.6) 3 (1.4) 2 (2.6) 1 (0.9) 1 (0.5)

Decision support n (%)/Mean (SD)
Range

Type of cardiac medications
 a) ACEI/ARB 204 (50.6) 96 (45.9) 108 (55.7) 89 (49.2) 115 (51.8) 44 (56.4) 53 (48.2) 107 (49.8)
 b) Beta-blockers 319 (79.2) 162 (77.5) 157 (80.9) 146 (80.7) 173 (77.9) 60 (76.9) 88 (80.0) 171 (79.5)
 c) Diuretics 344 (85.4) 180 (86.1) 164 (84.5) 154 (85.1) 190 (85.6) 66 (84.6) 95 (86.4) 183 (85.1)
Total number of medications 13.6 (4.8) 15.81(4.9) 11.21(3.3) 13.9 (4.8) 13.4 (4.7) 15.8 (4.9) 13.8 (5.2) 12.7 (4.2)
27 (4 – 31) 26 (5 – 31) 13 (4 – 17) 22 (5 – 27) 27 (4 – 31) 19 (7 – 26) 27 (4 – 31) 22 (5 – 27)